BVF Inc/il, Director Other at Kymera Therapeutics, Inc. (KYMR), bought 260,618 shares at $40.70 ($10.2M) on 2022-01-31, disclosed to the SEC on 2022-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.33 | 37,859 | $1.5M | 14.3% |
| 2 | $38.33 | 37,859 | $1.5M | 14.3% |
| 3 | $38.33 | 58,042 | $2.2M | 21.9% |
| 4 | $38.33 | 58,042 | $2.2M | 21.9% |
| 5 | $40.70 | 14,323 | $583K | 5.7% |
| 6 | $40.70 | 14,323 |
| $583K |
| 5.7% |
| 7 | $40.70 | 20,085 | $817K | 8.1% |
| 8 | $40.70 | 20,085 | $817K | 8.1% |
| Total | $38.96 avg | 260,618 | $10.2M | 100% |
| Filing → |
| PNT | SELL | 2023-12-20 | $427.3M | — | Filing → |
| CGEM | BUY | 2022-05-16 | $20.1M | — | Filing → |
| KYMR | BUY | 2022-05-09 | $8.3M | — | Filing → |